Results 41 to 50 of about 2,757 (78)

[Dosage optimization of major components of Yinchenhao decoction for metabolic associated fatty liver disease and its mechanism: an experimental study]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Gao Y, Xue R, Xu F, Chen L, Qiu J, Dou X.   +5 more
europepmc   +1 more source

[Research progress on the pathogenesis and clinical treatment of cirrhotic cardiomyopathy]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang KY, Liu L.
europepmc   +1 more source

[Causal relationship between the triglyceride<b>-</b>glucose index and non<b>-</b>alcoholic fatty liver disease: A Mendelian randomization study]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Wang Y, Chen Y, Wang Y, Chen L, Yin M, Xiao X, Huang J, Kuang J, Li Y.   +8 more
europepmc   +1 more source

[Screening of the anti-<i>Malassezia furfur</i> active fraction from <i>Rosa chinensis</i> Jacq. and study on its mechanism against seborrheic dermatitis]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Guo Z, Xi X, Zhong X, Qiu F, Huang Z.
europepmc   +1 more source

[Determination of squalene and oxidized squalene in edible oil by gas chromatography-tandem mass spectrometry and evaluation of the thermal stability of squalene]. [PDF]

Se Pu
Xiao GP, Liao DD, Li GS, Luo X, Yuan L.
europepmc   +1 more source

[A Study of the Association and Interaction Between Organophosphorus Pesticide Exposure and Insulin Resistance in Non-diabetic Adults]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Zhu X, Wang Z, Zhang Y, Li K, Zeng W, Guo B.   +5 more
europepmc   +1 more source

[Research progress on the correlation between Akkermansia muciniphila and cardiovascular diseases]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Jiang S, Gong L, Zheng H.
europepmc   +1 more source

[Interpretation of the "Expert consensus on the management of neonatal parenteral nutrition (2025)"]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Lin XZ, Zhang R, Chang YM, Li ZH, Liu XH, Bei F, Shen W, Tong XM, Chen C.   +8 more
europepmc   +1 more source

[<i>Ching Shum</i> Pills alleviates non-alcoholic fatty liver disease in mice by ameliorating lipid metabolism disorders]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Luo B, Yi X, Cai Y, Zhang S, Wang P, Li T, Yung KKL, Zhou P.   +7 more
europepmc   +1 more source

[Changes in hepatic phase Ⅱ detoxification enzymes and their mechanism in metabolic associated steatohepatitis (MASH) induced by MCD diet in mice]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Gao JQ, Zuo B, Pi CQ, Xiao M, Wang JX, Tao WJ, He Y.   +6 more
europepmc   +1 more source